AMANDA SAILLIEZ: Open Payments
NPI 1255305967 · MURPHYSBORO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 84 payments from 23 companies in 2025. Trend: 2023 $1,799 · 2024 $1,282 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $232 |
| AstraZeneca Pharmaceuticals LP | 13 | $224 |
| ABBVIE INC. | 12 | $182 |
| GlaxoSmithKline, LLC. | 11 | $166 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| PFIZER INC. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Amgen Inc. | 3 | $44 |
Products named: MOUNJARO, BREZTRI, VRAYLAR, TRELEGY ELLIPTA, GEMTESA, REXULTI, SPRAVATO, JARDIANCE.
Industry payments across IL — which companies pay providers there.
